Abstract:Wogonin (WOG) has been demonstrated to have anti-cancer activity, but the mechanisms remain unclear. In this study, new targets of WOG were predicted for lung cancer, bladder cancer, and colon cancer by Wogonin (WOG) has been demonstrated to have anti cancer activity but the mecha ism reman unclear. using bioinformatics methods. WOG might primarily suppress cancers via regulating arachidonic acid, In this study, new ta gets of WOG were predicted for lung cancer, bladder cancer, and colon cancer by using bioinf rmatics met ods WOG might primarily suppress cancer via r gulating arachidonic acid, Ras, MAPK, linoleic acid, PI3K-Akt, and folate biosynthesis pathways. 3-(4,5-dimethylthiazol-2-yl)-5-(3Ras, MAPK, linoleic acid, PI3K-Akt, and olate biosynthesis pathways. (4,5 dimethylthiazol-2-yl) 5 (3 carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay showed that WOG inhibited the carboxymethoxyphenyl)-2 4-sufophenyl) 2H-tetrazolium (MTS) assay showed that WOG inhbited the proliferation of A549 cells. Real-time quantitative reverse transcription PCR (RT-qPCR) results indicated that anti-lung cancer effect of WOG was acheved by regulaing the expression of 18 target genes, ncluding proliferation of A549 cells. Real-time quantitative reverse transcription PCR (RT-qPCR) results indicated AKR1B10, AKR1C3, BDNF, CAV1, CXCL2, CYP2B6, CYP4F3, DAO, EGF, ENO3, L6, PLA2G1B, that anti-lu g cancer e fect of WOG was achieved by reguating the xpresson of 8 targe Ien s, including AKR1B10 AKR1C3 BDNF CAV1, CXCL2, CYP2B6 CYP4F3 DAO, EGF, ENO3, IL6, PLA2G1B, PLA2G2F, PLA2G4A, PTGES, SLCO1B1, SLCO1B3, and TFAP2A. The Kaplan-Meier survival curves further PLA2G2F PLA2G4A PTGES SLCO1B1, SLCO1B3, and TFAP2A. The Kaplan M ier survival curves further confirmed that DAO, PLA2G1B, SLCO1B3 and TFAP2A were essential targets via which WOG affected lung cancer survival. Moreover, BDNF, FGF2, and PTGS1 were predicted o be the targets via which WOG confirmed that DAO PLA2G1B, SLCO1B3 and TFAP2A were essential tage s va which WOG affected lung cancer survival. Moreover BDNF, FGF2, and PTGS1 were predicted to be the tagets via which WOG alleviated cancer proliferation and invasion in bladder cancer. As for colon cancer, WOG might induce alleviated cancer pro iferation and invasion in bladder cancer. As for colon cancer, WOG might induce autophagy and inhibit proliferation by down-regulating NTF4 and TH. The study will provide clue for using WOG as a promising antineoplastic agent in basic and translational research, an bring light to the applicaton autophagy and inhibit proliferation by down-reguating NTF4 and TH. The study will provide clue for using of herbs containng WOG as food supplements. WOG as a promising antineoplastic agent in ba 2024 eijing Academy of Fod Sciences. Publishing services by Elsevier B.V. on behalf of KeAi (c) 2024 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V on behalf of KeAi Communications Co Ltd This is an open access artice under the CC BY NC-ND license CommunicationsCommunications Co.,Co., Ltd.Ltd. ThisThis isis anan openopen accessaccess articlearticle underunder thethe CCCC BY-NC-NDBY-NC-ND licenselicense (http:creativecommons.orglicensesby-nc-nd4.0).

de tficato of o e ta gets a d echa s s of ogo o g ca ce Identification of novel targets and mechanisms of wogoni n on lung cancer, badder cancer, and coon cancer bladde ca ce a d colo ca ce

Identification of Novel Targets and Mechanisms of Wogonin on Lung Cancer, Bladder Cancer, and Colon Cancer

Wogonin Inhibits Colorectal Cancer Proliferation and Epithelial Mesenchymal Transformation by Suppressing Phosphorylation in the AKT Pathway

Wogonin and its analogs for the prevention and treatment of cancer: A systematic review

Anti-tumor Activity of Wogonin, an Extract from Scutellaria Baicalensis , Through Regulating Different Signaling Pathways

Abstract 3724: Wogonin Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand's Antitumor Activity in Vivo Through H2O2-mediated Downregulation of X-linked Inhibitor of Apoptosis Protein and Cellular Inhibitor of Apoptosis Protein 1 and 2

Selective Anti-Tumor Activity of Wogonin Targeting the Warburg Effect Through Stablizing P53.

Wogonin Suppresses Tumor Growth in Vivo and VEGF-induced Angiogenesis Through Inhibiting Tyrosine Phosphorylation of VEGFR2.

Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis

Wogonin Attenuates High Glucose-Induced Human Breast Cancer Cell Mcf-7 Viability, Migration And Invasion Via The Expression Of Akt, Pkc Delta And P38 Mapk

Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism.

Effects of wogonin on the growth and metastasis of colon cancer through the Hippo signaling pathway

The Antitumor effect of wogonin, a lipoxygenase inhibitor, in both estrogen receptor-positive and -negative human breast cancers.

Wogonin Inhibits Tumor Angiogenesis Via Degradation of HIF-1α Protein.

Wogonoside inhibits TNF receptor-associated factor 6 (TRAF6) mediated-tumor microenvironment and prognosis of pancreatic cancer

Advances of Wogonin, an Extract from Scutellaria Baicalensis, for the Treatment of Multiple Tumors

Main Signal Pathways Underlying the Molecular Mechanisms of the Antitumor Effects of Wogonin

Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells

Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation

Therapy Effects of Wogonin on Ovarian Cancer Cells.

Wogonin Inhibits the Proliferation and Invasion, and Induces the Apoptosis of HepG2 and Bel7402 HCC Cells Through NF‑κB/Bcl-2, EGFR and EGFR Downstream ERK/AKT Signaling.